Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Morin

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
British Medical Bulletin|September 16, 2021
Treatment strategies for mosaic overgrowth syndromes of the PI3K-AKT-mTOR pathwayGabriel Morin, Guillaume Canaud
Kidney International|October 31, 2025
Drug repurposing in PIK3CA-related overgrowth spectrum: breakthroughs from overgrowth syndromes to kidney diseaseGabriel Morin, Pierre Isnard, Guillaume Canaud
EMBO Molecular Medicine|November 22, 2025
Vascular malformations: from genetics to therapeuticsGabriel Morin, Ilaria Galasso, Guillaume Canaud
Scientific Data|June 11, 2024
A Global Multi-Source Tropical Cyclone Precipitation (MSTCP) DatasetGabriel Morin, Mathieu Boudreault, Jorge L García-Franco
European Journal of Human Genetics : EJHG|June 6, 2025
First report of successful pregnancies after treatment with alpelisib for PIK3CA-related overgrowth spectrumGabriel Morin, Antoine Fraissenon, Caroline Chopinet, et al.
European Journal of Internal Medicine|February 4, 2019
Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapseGabriel Morin, Arthur Mageau, Khadija Benali, et al.
EMBO Molecular Medicine|May 19, 2025
Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibitionGabriel Morin, Alexandre P Garneau, Nabiha Bouzakher, et al.
The New England Journal of Medicine|July 17, 2024
Sotorasib for Vascular Malformations Associated with <i>KRAS</i> G12C MutationAntoine Fraissenon, Charles Bayard, Gabriel Morin, et al.
Kidney International Reports|August 25, 2020
COVID-19 in Patients on Maintenance Dialysis in the Paris RegionSarah Tortonese, Ivan Scriabine, Louis Anjou, et al.
The Journal of Experimental Medicine|January 26, 2022
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisibGabriel Morin, Caroline Degrugillier-Chopinet, Marie Vincent, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
British Medical Bulletin|September 16, 2021
Treatment strategies for mosaic overgrowth syndromes of the PI3K-AKT-mTOR pathwayGabriel Morin, Guillaume Canaud
Kidney International|October 31, 2025
Drug repurposing in PIK3CA-related overgrowth spectrum: breakthroughs from overgrowth syndromes to kidney diseaseGabriel Morin, Pierre Isnard, Guillaume Canaud
EMBO Molecular Medicine|November 22, 2025
Vascular malformations: from genetics to therapeuticsGabriel Morin, Ilaria Galasso, Guillaume Canaud
Scientific Data|June 11, 2024
A Global Multi-Source Tropical Cyclone Precipitation (MSTCP) DatasetGabriel Morin, Mathieu Boudreault, Jorge L García-Franco
European Journal of Human Genetics : EJHG|June 6, 2025
First report of successful pregnancies after treatment with alpelisib for PIK3CA-related overgrowth spectrumGabriel Morin, Antoine Fraissenon, Caroline Chopinet, et al.
European Journal of Internal Medicine|February 4, 2019
Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapseGabriel Morin, Arthur Mageau, Khadija Benali, et al.
EMBO Molecular Medicine|May 19, 2025
Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibitionGabriel Morin, Alexandre P Garneau, Nabiha Bouzakher, et al.
The New England Journal of Medicine|July 17, 2024
Sotorasib for Vascular Malformations Associated with <i>KRAS</i> G12C MutationAntoine Fraissenon, Charles Bayard, Gabriel Morin, et al.
Kidney International Reports|August 25, 2020
COVID-19 in Patients on Maintenance Dialysis in the Paris RegionSarah Tortonese, Ivan Scriabine, Louis Anjou, et al.
The Journal of Experimental Medicine|January 26, 2022
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisibGabriel Morin, Caroline Degrugillier-Chopinet, Marie Vincent, et al.
Pageof 2